00423nas a2200121   4500000000100000008004100001100001500042700001500057700001500072245019200087300001400279490000800293       2018                            d1 aMahaffey K1 aPerkovic V1 aMatthews D00aLetter by Matthews et al Regarding Article, "Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist"  a660 - 6610 v138